Merck in $700 million schizophrenia deal
480970
Swiss biotech company Addex Pharmaceuticals SA  said it could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug to treat schizophrenia, lifting its shares.
534842
The deal will settle claims that Merck overcharged Medicaid programs, and resolve charges over marketing.
138698
Another schizophrenia drug from the company shows promise in a clinical trial.
63904
A new study finds that an older antipsychotic drug is cheaper and equally effective for some patients with schizophrenia, sending makers of newer drugs scrambling to defend their products on Friday.
634297
Vanda Pharmaceuticals Inc. said Thursday its schizophrenia treatment was effective in a late-stage clinical trial, putting the biopharmaceutical closer to filing a New Drug Application with the Food and Drug Administration in late 2007.
700315
German drugmaker Merck KGaA   unveiled a surprise 16.6-billion-Swiss franc ($13.3  billion) deal to buy Swiss biotech firm Serono on Thursday,  creating a new force in European pharmaceuticals.
474629
Merck & Co Inc.  said on  Wednesday it agreed to settle tax disputes with the U.S.  Internal Revenue Service at a net cash cost of about $2.3  billion.
765384
NEW YORK, November 30  - Merck &amp; Co (MRK.NYS) has adopted a new compensation plan aimed at retaining its senior management officials in case of a possible takeover.
254545
An Indian drug maker, Ranbaxy Laboratories, said it had submitted a bid for the generics unit of the German drug maker Merck but did not disclose how much it was offering. Analysts say Merckâs generics unit could be worth as much as 5 billion euros ($6.6 billion). Merck said last month that it had started contacting companies that might be interested in acquiring its generics drugs unit. Two companies, Ranbaxy and the Actavis Group of Iceland, have publicly expressed an interest. Merck is based in Darmstadt.
238678
Pfizer, the world&#39;s largest drug maker, agreed Friday to pay $430 million to resolve personal-injury claims against a subsidiary that sold products containing asbestos in the 1970s.
751178
ZURICH/FRANKFURT  - German drugmaker Merck KGaA   MRCG.DE on Thursday unveiled a surprise 16.6-billion-Swiss   franc ($13.26-billion) deal to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
71950
Schering-Plough Corp  has agreed to buy Akzo Nobel NV's  drugs unit Organon BioSciences for 11 billion euros ($14.4 billion) in a bid to gain scale and diversify away from cholesterol medicine.
287707
Serono SA , one of the world's largest biotechnology companies, was bought yesterday by German chemical giant Merck KGaA in a deal worth more than $13 billion.
429824
TRENTON, N.J. - Pharmaceutical giant Merck & Co...
640611
Cambridge cancer drug maker Ariad Pharmaceuticals Inc. signed a major deal with Merck &amp; Co. Inc. yesterday in which the global pharmaceutical giant will pay $75 million to collaborate on developing and selling Ariad's experimental drug to treat sarcomas, a type of tumor that attacks fat, muscle, and bone.
157645
Biotechnology company Rigel  Pharmaceuticals Inc. RIGL.O has entered into a collaboration  pact with drugmaker Merck & Co. Inc. MRK.N to find treatments  for cancer and potentially other diseases, Rigel said on  Monday.
747971
More than 3,000 former users of Merck & Co's  withdrawn Vioxx pain drug have already signed up to take part in a $4.85 billion settlement deal that a federal judge on Friday declared was in the best interests of both sides.